← Back to patent-cliff list
阿齐沙坦酯钾盐/氯噻酮
Tier C — Watch / tradeAzilsartan Medoxomil Potassium/Chlorthalidone
武田药品工业株式会社
Originator
2011
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Thiazide-sensitive sodium-chloride cotransporter、AT1
Brand：Edarbyclor
Indications (approved)：高血压
Regional status
US
批准上市
2011-12-20
EU
无进展
2009-01-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Azilsartan Medoxomil Potassium/Chlorthalidone?
Approved indications include: 高血压.
When does the Azilsartan Medoxomil Potassium/Chlorthalidone patent expire?
No public expiry year is available for Azilsartan Medoxomil Potassium/Chlorthalidone yet; this page updates once verified.
How do I get a quote for Azilsartan Medoxomil Potassium/Chlorthalidone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24